Liver regeneration after liver resection: Clinical aspects and correlation with infective complications

Table 2 Preoperative variables in patients with liver malignancies (n = 27, mean ± SD)

Preoperative factor	Patients with malignancies
Age (yr)	61.04 ± 11.40
Weight (kg)	71.71 ± 12.33
Height (cm)	165.74 ± 8.82
BMI	26.02 ± 3.43
LV (cc)	2036.47 ± 804.95
FRLV (cc)	701.45 ± 343.56
Bilirubin (mg/dL)	0.88 ± 1.86
ALT (u/L)	57.26 ± 33.14
Albumin (g/dL)	3.44 ± 0.67
AST (u/L)	45.78 ± 38.28
Creatinine(mg/dL)	0.94 ± 0.24
GGT (u/L)	179. 33 ± 164.98
Platelet (103/μL)	278.96 ± 107.22
Prothrombin time (%)	95.93 ± 21.56
INR	1.05 ± 0.14
Steatosis (Hounsfield units)	1.10 ± 0.18
Portal vein diameter (mm)	13.83 ± 2.01
SV (cc)	315.38 ± 129.06
Glucose (mg/dL)	110.19 ± 38.08
Numbers of resected liver segments	4.67 ± 1.07

Steatosis was measured using the Hounsfield units of the liver from a basal CT scan and using the spleen Hounsfield unit as a reference value. Portal hypertension was measured indirectly by measuring the diameter of the common portal vein on portal venous phase images. BMI: Body mass index; LV: Liver volume; FRLV: Future remnant liver volume; ALT: Alanine aminotransferases; AST: Aspartate aminotransferases; GGT: Gamma-glutamyl transpeptidase; INR: International normalized ratio; SV: Spleen volume.